These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma. Zhang J, Chong CC, Chen GG, Lai PB. PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780 [Abstract] [Full Text] [Related]
4. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP. Oncotarget; 2015 Sep 22; 6(28):25093-108. PubMed ID: 26231037 [Abstract] [Full Text] [Related]
5. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M, Kong X, Wang H, Huang G, Ye C, He Z. Oncotarget; 2017 Jan 31; 8(5):8775-8784. PubMed ID: 28060739 [Abstract] [Full Text] [Related]
15. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Nagy Á, Lánczky A, Menyhárt O, Győrffy B. Sci Rep; 2018 Jun 15; 8(1):9227. PubMed ID: 29907753 [Abstract] [Full Text] [Related]
16. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models. Yu LX, Zhang BL, Yang Y, Wang MC, Lei GL, Gao Y, Liu H, Xiao CH, Xu JJ, Qin H, Xu XY, Chen ZS, Zhang DD, Li FG, Zhang SG, Liu R. Oncol Rep; 2019 Jan 15; 41(1):257-269. PubMed ID: 30542726 [Abstract] [Full Text] [Related]
20. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L, Chu F, Cao Y, Shao J, Wang F. Tumour Biol; 2015 Sep 15; 36(10):7439-47. PubMed ID: 25903466 [Abstract] [Full Text] [Related] Page: [Next] [New Search]